Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1

被引:190
作者
Doranz, BJ
Lu, ZH
Rucker, J
Zhang, TY
Sharron, M
Cen, YH
Wang, ZX
Guo, HH
Du, JG
Accaviti, MA
Doms, RW
Peiper, SC
机构
[1] UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104
[2] UNIV LOUISVILLE,DEPT PATHOL,JAMES GRAHAM BROWN CANC CTR,LOUISVILLE,KY 40202
[3] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
关键词
D O I
10.1128/JVI.71.9.6305-6314.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The chemokine receptor CCR5 is the major fusion coreceptor for macrophage-tropic strains of human immunodeficiency virus type 1 (HIV-1). To define the structures of CCR5 that can support envelope (Env)mediated membrane fusion, we analyzed the activity of homologs, chimeras, and mutants of human CCR5 in a sensitive gene reporter cell-cell fusion assay. Simian, but not murine, homologs of CCR5 were fully active as HIV-1 fusion coreceptors. Chimeras between CCR5 and divergent chemokine receptors demonstrated the existence of two distinct regions of CCR5 that could be utilized for Env-mediated fusion, the amino-terminal domain and the extracellular loops. Dual-tropic Env proteins were particularly sensitive to alterations in the CCR5 amino-terminal domain, suggesting that this domain may play a pivotal role in the evolution of coreceptor usage in vivo. We identified individual residues in both functional regions, Asp-11, Lys-197, and Asp-276, that contribute to coreceptor function. Deletion of a highly conserved cytoplasmic motif rendered CCR5 incapable of signaling but did not abrogate its ability to function as a coreceptor, implying the independence of fusion and G-protein-mediated chemokine receptor signaling. Finally, we developed a novel monoclonal antibody to CCR5 to assist in future studies of CCR5 expression.
引用
收藏
页码:6305 / 6314
页数:10
相关论文
共 60 条
[1]   CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B - Determinants of high affinity binding and receptor activitation are distinct [J].
Ahuja, SK ;
Lee, JC ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :225-232
[2]   REGULATED EXPRESSION OF FOREIGN GENES IN VACCINIA VIRUS UNDER THE CONTROL OF BACTERIOPHAGE-T7 RNA-POLYMERASE AND THE ESCHERICHIA-COLI LAC REPRESSOR [J].
ALEXANDER, WA ;
MOSS, B ;
FUERST, TR .
JOURNAL OF VIROLOGY, 1992, 66 (05) :2934-2942
[3]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN CD4-MEDIATED FUSION OF NONPRIMATE CELLS WITH HUMAN-CELLS [J].
ASHORN, PA ;
BERGER, EA ;
MOSS, B .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2149-2156
[5]   Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines [J].
Atchison, RE ;
Gosling, J ;
Monteclaro, FS ;
Franci, C ;
Digilio, L ;
Charo, IF ;
Goldsmith, MA .
SCIENCE, 1996, 274 (5294) :1924-1926
[6]   INTERNALIZATION OF THE HUMAN IMMUNODEFICIENCY VIRUS DOES NOT REQUIRE THE CYTOPLASMIC DOMAIN OF CD4 [J].
BEDINGER, P ;
MORIARTY, A ;
VONBORSTEL, RC ;
DONOVAN, NJ ;
STEIMER, KS ;
LITTMAN, DR .
NATURE, 1988, 334 (6178) :162-165
[7]   INTERLEUKIN-8 RECEPTOR-BETA - THE ROLE OF THE CARBOXYL-TERMINUS IN SIGNAL-TRANSDUCTION [J].
BENBARUCH, A ;
BENGALI, KM ;
BIRAGYN, A ;
JOHNSTON, JJ ;
WANG, JM ;
KIM, J ;
CHUNTHARAPAI, A ;
MICHIEL, DF ;
OPPENHEIM, JJ ;
KELVIN, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (16) :9121-9128
[8]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[9]  
BRASS LF, 1992, J BIOL CHEM, V267, P6044
[10]   THE BLOCK TO HIV-1 ENVELOPE GLYCOPROTEIN-MEDIATED MEMBRANE-FUSION IN ANIMAL-CELLS EXPRESSING HUMAN CD4 CAN BE OVERCOME BY A HUMAN CELL COMPONENT(S) [J].
BRODER, CC ;
DIMITROV, DS ;
BLUMENTHAL, R ;
BERGER, EA .
VIROLOGY, 1993, 193 (01) :483-491